DEK over expression as an independent biomarker for poor prognosis in colorectal cancer. - Wikidata - awgldk - TriplyDB

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

http://www.wikidata.org/entity/Q34884622

about

Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma.NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach.DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer.High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.DEK is required for homologous recombination repair of DNA breaks.DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients.Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma.MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene.The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.High expression of DEK predicts poor prognosis of gastric adenocarcinoma.Promotion of cell proliferation by the proto-oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.Expression of family with sequence similarity 172 member A and nucleotide-binding protein 1 is associated with the poor prognosis of colorectal carcinoma.Expression and significance of DOK2 in colorectal cancer.Prognostic role of DEK in human solid tumors: a meta-analysis.DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer.DEK oncogene is overexpressed during melanoma progression.Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence.TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion.

P2860

Q26783559-577C7B01-CBD9-408E-9762-E2AEF6663D2D Q33618700-53C355AB-D279-43A5-A0F9-01721130047E Q33759449-92DAF5AE-C628-40FC-9669-E68FBBD23AA7 Q33824446-00D8A194-D332-441F-A425-DD7835C192EB Q34121479-FBA7E917-17AB-462C-AD1B-C4CDAC77B72A Q34634946-8AAF91FC-C0A7-4BB0-8818-07BE8682FC2A Q34991689-7E910DA9-ED27-403B-9F48-7762CB0DDFC1 Q35120842-62A7F23F-1852-4B4C-AB00-F7C5C08ED978 Q35362468-2BA4103B-A5B3-466B-A0E7-951DC88000B7 Q35440426-4B2C0617-4F2F-4874-A446-AFB4DB63F5E1 Q36314320-B6E6DCBA-019C-4B36-AAD3-A4B48ABBACC4 Q36384979-43DA73F3-C17C-48A2-A371-54C4DEC3760E Q36572153-BE9A8CDE-B2F1-449B-B60A-4DCEA1DC3EFD Q36651966-354AA5FE-CEA8-48E3-A40E-58EB0D788FDA Q36707129-7D5C8CE0-699D-4E49-A9A2-FB3E10D99122 Q37269117-C8FB00B4-5F00-4D99-97E7-97ECA6A9440F Q37600150-0C09575E-EB53-466D-BBCF-30966BAA2F6A Q37714805-960C6025-A00A-443D-B30C-AF4A6C80BF8A Q38611667-67FBBF05-4B10-4BF7-ADE1-A9C65E2D5A84 Q38697212-A9A20E78-BAF0-4302-8E61-5671B5AAAE95 Q41618534-988D98C1-779C-47F6-82EC-4DF2B1840DE6 Q42247530-FA5DC439-058B-4408-851B-D3AA0E5FFC0C Q47129657-9D5E0A25-4927-45D1-911A-309159FBC2E5 Q47141452-259D5AAE-A60D-455B-A1CD-814D86E806DC Q51300425-962FA365-9C24-4AB1-AF4B-5D46ECE21EF7 Q52656023-D0FF7754-8FDD-415F-BFE6-EB67F35C2E37 Q52779937-06886393-FD6C-4790-BF9A-7B7C4FF5AB5E Q55345164-00202755-D985-4876-8371-76657E84BDB1

P2860

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

http://www.wikidata.org/entity/Q34884622

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

@ast

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

@en

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

@nl

type

label

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

@ast

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

@en

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

@nl

prefLabel

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

@ast

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

@en

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

@nl

P1433

Q34884622-A75890A5-4E04-45E9-BC06-98DCBD5078CE

P1476

Q34884622-F35FAD77-95AD-4BC4-AA9F-E912A9868A8F

P2093

Q34884622-109AB644-EFC0-49F9-9E83-343D2F2BE9BA

Q34884622-19459444-9CBD-43C1-8ED6-9BBBC5B813E5

Q34884622-55E11A15-27C4-4278-8679-007510F4A124

Q34884622-6E6DFFE6-71DE-4025-8414-2886BA9BB9B2

Q34884622-99891E9B-CE1D-419B-9017-61A61BC549CA

Q34884622-B0518CAD-B135-4CB1-BDF0-03C9B46FE616

Q34884622-E77E6C88-237F-4CC2-B2D2-3E7EFB8016B7

Q34884622-EA777498-6B7F-4F52-A497-37F61CE68DF4

P2860

Q34884622-16B4D915-429A-4FB8-93AF-88EC82D7B6E1

Q34884622-1B4EA1B5-0084-4149-8CAC-15B84529B010

Q34884622-28AEDDC6-B904-4A72-8F98-A230BA32E53A

Q34884622-2C078245-C82C-4BFA-B552-5A8CBEE8AFC1

Q34884622-524BE080-68D9-440B-BB31-BC9B4BDD6405

Q34884622-5C7C972C-949A-4BCD-817E-38FB11692E04

Q34884622-6281146A-AB72-481D-9F20-F6643BEE9520

Q34884622-65B1201A-9044-4351-AEB5-C41069B24B21

Q34884622-68A03B74-BA87-45D7-B5B4-313DE8DE9F9B

Q34884622-6BDA6707-A8E5-40F5-A270-C6B2B98FE774

P2888

Q34884622-C7879567-59B8-49D4-8EF9-87420A0E80E3

P304

Q34884622-B996471A-DEC3-4FCC-950C-B0D9F4244764

P31

Q34884622-02E54D05-BBE9-4BF5-8D89-DCB943C6781E

P356

Q34884622-9B190970-C757-4D75-A65D-50ABE86C7CFE

P407

Q34884622-FDF767E1-40F2-4FBC-B2EE-48BCD457D007

P478

Q34884622-58629B4E-C4EA-447C-A691-ABF7A04D55A0

P577

Q34884622-6B45C09D-2CC3-46AD-BCA9-6DD927B027B5

P5875

Q34884622-60CB27B8-4A5F-45CF-AEB3-38DAEF99ED57

P6179

Q34884622-6D395A07-B301-4C90-925D-A3ADF788F482

P698

Q34884622-C13900B5-E5E8-4FB6-B1B3-05A49A3B9B7E

P921

Q34884622-964FD8C7-EA4A-48BC-811E-A0D936052A0A

Q34884622-FC414998-1B91-4AAC-8A93-16D1A60A0788

P932

Q34884622-34D7E92E-6D1D-48F3-9B5D-4113AD9805FA

P356

1471-2407-13-366

P1433

P1476

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

@en

P2093

Guang Jin

http://www.w3.org/2001/XMLSchema#string

Jinzi Li

http://www.w3.org/2001/XMLSchema#string

Junjie Piao

http://www.w3.org/2001/XMLSchema#string

Lijuan Lin

http://www.w3.org/2001/XMLSchema#string

Wenbin Gao

http://www.w3.org/2001/XMLSchema#string

Yingshi Piao

http://www.w3.org/2001/XMLSchema#string

Yue Ma

http://www.w3.org/2001/XMLSchema#string

Zhenhua Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Nuclear speckles: a model for nuclear organelles

The human DEK oncogene regulates DNA damage response signaling and repair

The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA

Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis

The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer

Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status.

The identification of novel therapeutic targets for the treatment of malignant brain tumors.

Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

Control of tumorigenesis and chemoresistance by the DEK oncogene

P2888

1471-2407-13-366

P304

366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-13-366

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

254260440

http://www.w3.org/2001/XMLSchema#string

P6179

1042221615

http://www.w3.org/2001/XMLSchema#string

P698

23902796

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3751154

http://www.w3.org/2001/XMLSchema#string